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Conclusions: Both thrombin and plasmin were able to induce
proteoglycan release in a dose-dependent manner. PAR1 and PAR2
antagonists were not able to inhibit the thrombin- and plasmin induced
proteoglycan release. Furthermore, the PAR agonists TFLLR-NH2 and
SLIGKV failed to induce proteoglycan release. This suggests that both
thrombin and plasmin induce proteoglycan release and that both are
able to damage the human cartilage in a PAR-independent manner.
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STUDY OF THE ASSOCIATION BETWEEN BONE SIALOPROTEIN,
HYPERTROPHIC DIFFERENTIATION OF CHONDROCYTES AND
CARTILAGE LESIONS IN OSTEOARTHRITIC CARTILAGE
L. Pesesse1, C. Sanchez1, D.A. Walsh2, C. Baudouin3, P. Msika3,
Y. Henrotin1. 1Univ. of Lie`ge, Lie`ge, Belgium; 2Univ. of Nottingham,
Nottingham, United Kingdom; 3Lab. ExpanSci., IRD Direction, Epernon,
France
Purpose: Chondrocyte hypertrophy is commonly observed in OA
cartilage, associated with matrix mineralization and vascularization.
In previous work, we demonstrated that hypertrophic differentiation
of chondrocytes is initiated by serum-enriched medium in long-term
culture in alginate beads suggesting a role played by blood supply in the
hypertrophic differentiation of chondrocytes in OA.
This study aims to investigate the production of Bone SialoProtein (BSP),
an angiogenesis enhancer known to promote endothelial cell attachment
and migration, during hypertrophic differentiation of OA chondrocytes
and its expression in OA cartilage according to the severity of the
lesions by immunohistochemistry. This work was supported by an OARSI
scholarship grant.
Methods: Articular OA chondrocytes were cultured for 28 days in alginate
beads in culture medium containing 2% Ultroser G (UG) or 10% Fetal
Bovine Serum (FBS). DNA was quantiﬁed by ﬂuorimetry. The expression
of BSP and hypertrophic differentiation marker COL10A1 was evaluated
by RT-PCR. Alkaline phosphatase (AP) activity and 5′phosphodiesterase
activity of NTPPPH were quantiﬁed by speciﬁc enzymatic methods.
Western Blot analysis was performed from chondrocyte protein extracts
with anti-BSP antibody (LFMb-24).
Human bone and cartilage samples from 9 post-mortem (PM) individuals
and 24 patients undergoing total knee joint replacement for OA
(TKR) were formalin-ﬁxed, EDTA-decalciﬁed and wax embedded. Five
mm tissue sections were cut and stained. Macroscopic chondropathy
score described previously by Walsh et al. and the modiﬁed Mankin
score were respectively used to establish macroscopic and microscopic
chondropathy scores for individual knees. BSP was immunolocalized in
cartilage using anti-BSP monoclonal antibody (LFMb-25) and anti-BSP
polyclonal antibody (ab52128) to conﬁrm the speciﬁcity of staining. A
scoring system was established according to the location of the stained
cells in cartilage (0: no staining – 1: staining in the superﬁcial layer –
2: staining in the middle layer – 3: staining in the deep layer). All
histological scoring was undertaken twice blinded to patient group, using
a Zeiss Axioscop-50 microscope.
Data were analyzed using GraphPad Prism software, version 5.
Associations between variables were reported as Spearman’s rank
correlation coefﬁcients (r).
Results: In alginate beads, chondrocytes cultured in serum-
supplemented medium underwent a hypertrophic differentiation process
characterized by the increased expression of hypertrophic differentiation
markers. In the same manner, the expression of BSP increased in FBS
with long-term culture and was associated with markers of chondrocytes
hypertrophy; COL10A1 (r = 0.67; p =0.005), AP (r = 0.8; p = 0.0002) and
NTPPPH (r = 0.68; p = 0.004). After 21 days, BSP was also detected in
protein extracts of chondrocytes cultured in serum but not in UG.
BSP-immunoreactive chondrocytes were localized at increased depth in
cartilage from OA joints (2.3±0.63) than from PM controls (0.56±0.54),
(p = 0.005). The expression of BSP in patients with OA was associated with
the severity of macroscopic cartilage lesions (r = 0.5; p = 0.01). Highly
signiﬁcant correlations were also observed with the modiﬁed Mankin
score (r = 0.71; p < 0.0001) and with the individual scoring criteria of
cartilage surface integrity (r = 0.51; p =0.01), chondrocyte appearance
(r = 0.44; p =0.03) and proteoglycan loss (r = 0.61; p =0.001).
Conclusions: Genetic and protein expression of BSP are associated with
hypertrophic differentiation of chondrocytes in OA. Location of BSP in
OA cartilage is clearly associated with macroscopic and microscopic
cartilage lesion severity. BSP may be an important factor in cartilage
degradation and its role as an angiogenesis enhancer in OA is still to be
demonstrated.
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COMMON AND EARLY CARTILAGE DEGENERATION PATTERNS IN
AGING AND OSTEOARTHRITIC HUMAN KNEES
C. Pauli1, S. Duffy1, S. Grogan2, A. Hasegawa1, M.K. Lotz1, D.D. D’Lima2.
1The Scripps Res. Inst., La Jolla, CA, USA; 2Scripps Hlth., La Jolla, CA, USA
Purpose: A better understanding of early tissue degeneration patterns
in the aging knee can help to ﬁnd new targets for osteoarthritis (OA)
prevention and treatment. The objective of this study was to identify
common and early morphologic patterns of cartilage degeneration during
human joint aging, and to establish their correlation with changes in
anterior cruciate ligament (ACL), meniscus, and synovium.
Methods: 130 human knees (67 donors, age range 23–96), obtained
from tissue banks, were divided into eight age groups: 21–30 (n =8),
31–40 (n =6), 41–50 (n =18), 51–60 (n =21), 61–70 (n =22), 71–80
(n =20), 81–90 (n =26) and >91 (n =9). All cartilage compartments were
macroscopically assessed according to the ICRS mapping system by using
a modiﬁed Outerbridge grading system. Menisci and ACL were evaluated
macroscopically and by histopathology. Synovium histopathology was
assessed using a modiﬁed Krenn grading system for chronic synovitis.
Osteophytosis was macroscopically assessed.
Results: We found a strong correlation between cartilage, meniscus,
and ACL degeneration with aging. The earliest cartilage lesions were
detected in the central area of the lateral tibial plateau that is not
covered by the meniscus, followed by changes in patella and trochlea.
Degeneration in the medial femoral condyle appeared later than in
the tibia plateau but progressed rapidly to become the most severely
affected among all articular surfaces. On the other hand, degeneration
in the lateral femoral condyle progressed less rapidly in all age groups.
In the lateral TFJ, more knees had a higher tibial than femoral average
grade at all ages. This pattern was similar but reversed with aging in the
medial TFJ. Degeneration of the meniscus-covered tibia surface correlated
with increased meniscus degeneration. A common macroscopic pattern
(33%) was degeneration in tibia and meniscus with a normal-appearing
femoral condyle. In 14% we found degenerative changes in the tibia
while menisci and femoral condyles were normal. In 18% we found
a macroscopically normal meniscus while there were degenerative
changes in tibia (uncovered portion) and femoral condyle. ACL scores
increase with cartilage degeneration at all stages of OA development and
correlated with cartilage as well as meniscus degeneration, especially
in the medial compartment. Moderate and severe OA groups showed
signiﬁcantly higher ACL substance scores than the minimal/mild OA
groups. Synovitis correlated with cartilage degeneration and the presence
of osteophytes. In our donor population every knee with osteophytes was
accompanied by synovitis.
Conclusions: By examining younger age groups, we were able to
identify early patterns of cartilage degeneration. Our data suggest that
in younger subjects the lateral tibia plateau shows the earliest and
most severe degeneration. Contrary to the notion that the medial
TFJ compartment in severe OA is most affected, we found that the
lateral tibia plateau is affected the earliest. The uncovered part of the
tibia plateau degenerated ﬁrst, followed by early surface degeneration
in the inner rim of the menisci. Degeneration of the covered tibia
region increased with cumulative meniscus degeneration, supporting
the protective role of menisci. This cross-sectional study emphasizes the
importance of interaction of the different joint tissues in OA initiation
and progression and deﬁnes speciﬁc regions in the joint for future studies
on biomechanical and cellular factors that determine early stages of OA
initiation to reveal novel targets for preventing or delaying OA.
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COMPARISON OF SYNOVIAL FLUID ARGS CONCENTRATIONS AT
BASELINE AND ONE-YEAR POST-ACL RECONSTRUCTION COMPARED
TO HEALTHY, MATCHED CONTROLS
T.W. Tourville1, R.J. Johnson1, S. Naud1, J.R. Slauterbeck1, A. Struglics2,
S. Lohmander2, B.D. Beynnon1. 1Univ. of Vermont, Burlington, VT, USA;
2Lund Univ., Lund, Sweden
Purpose: The clinical signs and symptoms of post-traumatic
osteoarthritis (PTOA) following severe joint injury, such as that associated
with anterior cruciate ligament (ACL) tears, typically present 10–20 years
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earlier than in matched, non-injured controls. By the time subjects with
these injuries become symptomatic, irreversible damage to the articular
cartilage and surrounding tissues has likely occurred. Consequently,
much attention has been devoted to biomarker discovery and validation
in hopes of identifying prognostic markers of PTOA onset and early
progression (when intervention may help prevent future degradation),
as well as targets for therapeutic intervention. The onset of PTOA includes
change of the articular cartilage, with one of the initial events involving
a change of matrix proteoglycan content. One process by which this
occurs is through the enzymatic cleavage of aggrecan at the (392)Glu-
(393)Ala bond in its interglobular domain, which results in the release
of N-terminal (393)Alanine-Arginine-Glycine-Serine (ARGS) neoepitopes
into the surrounding synovial ﬂuid (SF). Increased concentration levels
of this proteoglycan degradation marker have been described soon
after acute trauma to the ACL, as well as in long-term follow-up after
menisectomy. It has not, however, been described how this marker
changes over the initial year following ACL-reconstruction (ACL-R)
compared to healthy, matched controls, which was the focus of this
study.
Methods: A case-control study design with nested prospective
component was used to evaluate sf-ARGS levels in ACL-injured subjects
at the time of ACL-R (mean time after injury = 70.1 days, range: 18–155)
as well as at one year following ACL-R. Concentrations were compared
to a group of age, sex, activity level, and BMI-matched control subjects
at baseline and one year follow up. Entry criteria for injured subjects
included: Age at the time of ACL-R = 14–55yrs; BMI =18.5–30, Tegner
activity score >4; no relevant knee pathologies other than the index
ACL injury and reconstruction; normal lower extremity alignment; <2/3
menisectomy; and <Gr IIIb articular cartilage lesions. All reconstructions
took place within 6 months of injury, and all subjects participated in
a standardized rehabilitation program. Entry criteria were similar for
control group subjects, however these individuals had healthy knees
as determined by thorough history, clinical examination, and 3T MRI.
Synovial ﬂuid (SF) samples were obtained via non-lavage arthrocentesis
from all subjects at baseline and one-year follow-up evaluations. Samples
were centrifuged at 4,000xg for 20 minutes at 4°C to remove debris, and
supernatant stored at −80°C until time of assay. ARGS concentrations
were evaluated via sandwich immunosorbent electrochemiluminescence
assay using previously described methods by investigators blinded to
subject group and follow-up interval. Within and between group ARGS
levels were compared statistically via Wilcoxon rank-sum tests.
Results: Distributions of data in both groups were skewed; consequently,
non-parametric statistics were utilized. ARGS levels were not different
between groups at baseline, or within the control group from baseline to
follow-up (Table 1). Injured group ARGS levels were signiﬁcantly lower
at follow-up compared to baseline and follow-up control group levels.
Conclusion: Decreased ARGS levels observed in ACL-R subjects at 1-year
follow-up compared to those observed in healthy controls may be
secondary to new synthesis of full-length aggrecan in response to
the injury, the reconstruction, or altered loading of the joint during
ACL-R rehabilitation. However, the temporal or cyclic patterns of ARGS
production following ACL injury and subsequent reconstruction may not
be adequately elucidated to draw clear conclusions at this time.
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KNEE CARTILAGE RELAXATION TIMES AT 3 MONTHS FOLLOWING
PARTIAL MENISCECTOMY
S. Wu, B.T. Feeley, X. Li, R.B. Souza. Univ. of California, San Francisco, San
Francisco, CA, USA
Purpose: Knee osteoarthritis (OA) is a degenerative joint disease that
affects articular cartilage. Previous studies suggest that meniscectomy
increases risk of knee OA. The microscopic progression of OA begins
with loss of proteoglycan and disruption of the collagen network. Recent
advances in magnetic resonance imaging (MRI) markers, T1rho and T2,
allow for early detection of these biochemical changes. The aim of
this study is to evaluate the effects of partial posterior horn medial
meniscectomy on relaxation time changes of the articular cartilage. We
hypothesize that T1rho and T2 values will be increased at 3 months after
meniscectomy in comparison to the pre-surgical values.
Methods: Six patients (5 male, age: 48.5±12.5 years, BMI:
29.8±3.4 kg/m2) with MRI conﬁrmed tears of the posterior horn of
the medial meniscus were scheduled for meniscectomy. MRI was
performed on each subject’s injured knee using a 3T scanner and an
8-channel phased-array knee coil before surgery and 3 months post-
operatively. The following sequences were collected using previously
established parameters: high resolution water excite SPGR, T1rho and T2
relaxation time maps. Relaxation time maps were made using established
ﬁtting routines. Cartilage segmentation was performed on registered
baseline SPGR images and overlaid on the maps for quantiﬁcation.
Subsequent follow-up maps were registered to baseline images and
cartilage relaxation times were quantiﬁed with the same regions-of-
interest. Medial femoral and tibial compartments were divided into 5
and 3 sub-compartments, respectively, reﬂecting regions of lesser weight
bearing, cartilage-meniscus and cartilage-cartilage contact. Paired t-tests
were performed to determine signiﬁcant changes in cartilage relaxation
times from baseline.
Results: Signiﬁcant increases in T1rho relaxation times of the medial
femoral condyle directly overlying the posterior horn of the medial
meniscus (MFC-4) as well as the posterior medial femoral condyle
(MFC-5;). Average T1rho in the MFC-4 region increased 19% (36.3±4.3ms
at baseline and 43.1±5.2ms at 3-month follow up; p =0.049). Similarly,
